Dental drug reference software compared: Lexidrug for Dentistry vs Epocrates on price and dental fields

Most drug reference comparisons are written for physicians and pharmacists, and dentists are left to work out how much of the advice transfers. Not much of it does. A general drug database answers the prescriber's question, which is what to give and at what dose. A dental practice needs a second question answered too, which is what the patient is already taking that changes what happens in the chair over the next forty minutes.

Here is what the two products dentists actually weigh against each other cost, what the dental-specific one adds, and when the general one is genuinely enough.

How much does a dental drug reference cost?

One of these publishes a price and the other does not, which is the first practical difference.

Lexidrug figures were read at Wolters Kluwer and the two app store listings in September 2026. The epocrates+ figure was read at the vendor in August 2026. We do not repeat software-directory numbers, and directory pages currently disagree with each other on the epocrates+ rate, so confirm it at checkout rather than from a listicle.

The $29.99 a month line deserves a warning, because it is the number a dentist is most likely to find first and the one most likely to disappoint. That subscription buys the Hospital Pharmacist package, which both app stores name explicitly. It is not the dental product. Subscribing to it and expecting dental fields is the single most common way to waste $360 a year in this category, and we set out what each tier actually includes in our guide to Lexidrug subscription plans.

What does Lexidrug for Dentistry actually add?

Three fields and one tool, and they are the whole argument for the product.

Wolters Kluwer builds the dental monographs around local anesthetic and vasoconstrictor precautions, effects on dental treatment, and dental dosing. Those are not relabeled versions of general fields. They are answers to questions a general database never asks, because no physician needs them. The vendor puts dental-specific pharmacology across more than 8,000 prescription drugs, over-the-counter products and natural products, and adds a lesion diagnosis aid plus a drug interaction and allergy screener.

Think about what the vasoconstrictor field is for. A patient arrives on a medication list you did not write, and you are about to give a local anesthetic containing epinephrine. Whether that combination deserves caution depends on what else they take, and it is a genuinely recurring question in general practice rather than an exotic one. A general drug reference will tell you plenty about each drug separately and will not put that answer where you need it.

The same is true of the effects-on-dental-treatment field. Drugs that cause xerostomia, gingival overgrowth, altered bleeding or delayed healing are ordinary drugs with ordinary indications, and their dental consequences are a footnote in a general monograph. Anticholinergic load is the clearest example, since dry mouth is a predictable class effect and it changes caries risk and denture tolerance; we keep a working reference on anticholinergic burden drugs for exactly that reason.

Is Epocrates good enough for a dental practice?

For a real slice of practices, yes, and it is worth saying so plainly rather than steering everyone to the expensive answer.

Epocrates is a strong, fast general drug reference with a free tier that includes monographs, an interaction checker and pill identification. If what you mainly do is confirm an interaction against a short medication list, identify a tablet a patient brought in a bag, and check a dose for something you prescribe often, the free tier does that. epocrates+ at $179.99 a year adds disease content, lab guidance and clinical guidelines, which is more useful to a prescriber managing conditions than to a dentist managing a procedure.

What Epocrates will not do is answer the chairside question in one lookup. You can get there by reading the general monograph and applying your own dental pharmacology, which is exactly what dentists did for decades and still do competently. The dental product is not buying you knowledge you lack. It is buying you the time it takes to derive the answer, on a day with a full book. Whether that is worth an unpublished annual fee depends on how often your patients arrive on complicated medication lists, which in a practice weighted toward older adults is most of them.

We compare the two general products directly in Epocrates vs Lexicomp, and the full cost breakdowns sit in Epocrates cost and the Lexicomp subscription price.

Is a printed dental drug handbook still worth buying?

The printed handbooks in this category, including the long-running dental drug references and the ADA-associated handbooks, still sell steadily, and the reason is not nostalgia. A book has three properties a subscription does not: it costs once, it does not expire, and it works when the practice management system is down.

The tradeoff is the obvious one. A printed edition is a snapshot, and drug safety information is the category where snapshots age badly. New warnings, new interactions and withdrawn products all land between editions. For a solo practice that sees a stable patient population and prescribes a short, familiar list, a current edition on the desk is a defensible choice. For a practice doing surgical extractions on medically complex patients, it is not, because the cases where the book is out of date are precisely the cases where you needed it.

A practical middle path many practices land on: keep a current handbook for the routine lookups everyone does, and hold one online subscription for whoever handles the complex medical histories. That costs less than licensing the whole team and covers the risk where it actually sits.

What a dental practice should check before it subscribes

Four things, in this order.

Check the school and association routes first. If anyone in the practice holds a faculty appointment or an academic affiliation, institutional access may already exist. Dental schools license this content widely, and the mobile app is usually included through an access code. Paying personally for something an affiliation already covers is common.

Decide who actually needs a seat. Hygienists, assistants and front-desk staff taking medical histories have different needs from the dentist doing the procedure. A single seat used by the person who reviews complex histories often beats a thin licence spread across everyone.

Ask for the dental package by name. Asking a Wolters Kluwer salesperson about Lexidrug gets you a quote for something. Asking for Lexidrug for Dentistry, and confirming Dental Lexi-Drugs is in the package, gets you a quote you can compare against next year's.

Put a renewal date in the diary. Professional subscriptions renew quietly, and an unpublished annual fee is harder to sanity-check than a listed one. Practice owners who review this line properly tend to be the ones who already turn the bookkeeping export into a readable P&L each quarter, because a recurring software line is invisible until someone puts it next to the revenue it supports.

Which should you buy?

The honest summary is that the dental product is a genuine product rather than a marketing tier, and it is also not something every practice needs. It earns its money in practices where patients arrive on long medication lists and where procedures draw blood. It is hard to justify in a practice where neither is usually true.

One thing none of these references does, dental or general, is check anything on its own. They wait to be opened. That is fine when you already suspect a problem and it is no help at all when the interaction is in a medication list nobody flagged. That gap is the reason we built what we built, and it is covered in our roundup of the best drug reference apps.